Positrigo
Latest round
- Series B
Last raised
- Oct 2022
Total raised
- $9.8M
Investors
- 8
About Positrigo
Based in Switzerland, Positrigo AG develops innovative medical imaging technologies, particularly ultra-compact Positron Emission Tomography (PET) systems.Founded in 2018, Positrigo AG operates from Zurich, Switzerland, focusing on the development of advanced Positron Emission Tomography systems.Positrigo AG specializes in the development and commercialization of ultra-compact Positron Emission Tomography (PET) systems, with its flagship product being the NeuroLF device. This innovative imaging technology provides functional brain imaging, primarily focusing on the diagnosis of dementia, including Alzheimer’s disease, along with various other neurological disorders such as epilepsy and neuro-oncology. The NeuroLF system is designed to make precision medicine and functional imaging accessible to healthcare providers and patients worldwide, significantly reducing the cost compared to traditional PET devices. Key customer segments include hospitals, research institutions, and clinics that require advanced imaging solutions to enhance patient care.Positrigo's revenue model is centered around the direct sale of its NeuroLF PET systems to healthcare providers and research institutions. Additionally, the company engages in strategic partnerships to enhance its distribution capabilities, which includes appointing exclusive distributors in key markets, such as Qualimedis in France. The pricing structure for the NeuroLF system and associated services is tailored to institutional clients, enabling them to incorporate advanced imaging technology into their diagnostic offerings. Revenue is generated primarily through the initial sale of the NeuroLF devices, as well as additional services such as maintenance and technical support, creating a comprehensive customer relationship. Looking ahead, Positrigo plans to expand its market presence by targeting additional regions for product distribution, thus enhancing accessibility to its innovative imaging technologies.
Who invested in Positrigo
8 investors across 3 rounds
See all investors in Positrigo
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Positrigo
Who invested in Positrigo?
Positrigo has 8 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Positrigo raised?
Positrigo has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Positrigo last raise money?
Positrigo's most recent round on record is a Series B, in Oct 2022.
What does Positrigo do?
Based in Switzerland, Positrigo AG develops innovative medical imaging technologies, particularly ultra-compact Positron Emission Tomography (PET) systems.
Where is Positrigo headquartered?
Positrigo is headquartered in Zurich, Switzerland.
Which VCs invest in companies like Positrigo?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back medical devices & equipment companies at Positrigo's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series B
Raising like Positrigo? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.